-
EU unveils strategy to boost Arctic presence
-
Vote count begins in Alberta secession referedum, testing Canada unity
-
How recent controversies have rocked the US death penalty debate
-
Ukraine claims US missile holdup as Trump floats summit without Zelensky
-
Adams facing long injury layoff as Rams' problems deepen
-
Detained Suu Kyi receives UK royal package: Myanmar govt
-
US judge orders Saudi engineer held in OpenAI case
-
Japan successfully launches probe in historic Mars moon mission
-
Maddison sparkles as Spurs end Premier League winless run
-
US to auction deep sea mining leases off American Samoa
-
Maddison sparkles on Spurs return as win drought ends
-
Australian lawmaker hurt in car attack underwent surgery overnight: PM
-
Trump says ready to meet with Putin and Xi in China
-
Japan launches rocket for potential world first Mars moon mission
-
The young lawmaker making Brazil's Lula 'king of the selfie'
-
Ethiopia PM warns Eritrea of 'severe consequences' if supports enemies
-
Christiane Amanpour to leave CNN after 43 years
-
Boland grabs opportunity for Australia as South Africa struggle in second Test
-
Ronaldo handed 30-day suspension after walking out on Portugal
-
Ronaldo handed 30-day suspension: Portuguese federation
-
Netanyahu basks in Trump endorsement week before election
-
France announces curfews as government grapples with unrest
-
Saudi airport closure disrupts life in kingdom's capital
-
Boland sets pace as South Africa struggle
-
Ramaphosa tells South Africa to prepare for loss of US-Africa trade deal
-
Ukraine on back foot as Kremlin moots US, China meeting
-
France presses resale platforms to remove 'stolen' goods after unrest
-
'Stay home!': Tourists find themselves in a France convulsed by protests
-
Yamal v PSG: Ballon d'Or backdrop to Champions League showdown
-
Kenyan cult leader guilty on all charges over 191 starvation deaths
-
Araujo says too soon to talk about permanent Liverpool move
-
Eagles star Hurts to miss rest of NFL season: reports
-
US wants to be 'strong partner' for central Asia: Rubio
-
Oil-rich Alberta votes on Canada breakup
-
'Special' to face friend Perez in Champions League, says Liverpool's Iraola
-
Israel announces arrests after West Bank settler attacks on Westerners
-
Monitor says Indonesia fires have burned nearly two million hectares
-
Guehi insists players have 'trust and belief' in Man City after charges
-
French PM says could declare state of emergency over unrest 'if needed'
-
UN climate panel head wants swift end to deadlock over key scientific report
-
Albanian PM warns of 'red line' after days of unrest
-
PM calls for curfews in France as govt grapples with unrest
-
Putin, Xi and Trump could meet at APEC summit: Kremlin
-
Man City's Semenyo out for up to eight weeks
-
Microsoft exits data centre deal in blow to UK AI ambitions
-
Australian lawmaker critically hurt in 'violent' vehicle attack
-
European stocks retreat as France violence spreads
-
England women's coach Wiegman signs two-year contract extension
-
North Korea warns 'grave situation' prevailing along border
-
Louvre blocked as France grapples with unrest
Medical Care Technologies (OTC PINK:MDCE) Begins Advanced Internal Beta Testing of MDCE Melanoma Scan Imaging Platform
Company initiates structured internal testing focused on platform stability, workflow optimization, and image consistency evaluation
MESA, AZ / ACCESS Newswire / June 12, 2026 / Medical Care Technologies, Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on artificial intelligence, imaging technologies, and digital wellness platforms, today announced the commencement of internal beta testing for its MDCE Melanoma Scan Beta platform.

The testing phase is designed to evaluate platform stability, workflow performance, image management functionality, interface responsiveness, and image consistency processes as the Company continues development of its AI-assisted imaging platform.
The MDCE Melanoma Scan Beta platform is being developed as an image organization and monitoring system intended to support longitudinal image management workflows. Internal testing will focus on identifying opportunities for refinement, validating core platform functions, and optimizing the overall user experience.
"Beginning structured internal testing represents an important milestone in our development process," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "Our focus is on building a stable, scalable, and well-engineered imaging platform through disciplined testing and continuous refinement."
The Company views the platform as part of its broader strategy involving AI-assisted imaging technologies, software infrastructure, and future digital wellness applications.
Medical Care Technologies emphasized that the MDCE Melanoma Scan Beta platform remains in beta-stage development. The pre-screening platform is not intended to treat, cure, or prevent any disease or medical condition and has not been reviewed or cleared by the U.S. Food and Drug Administration.
The Company expects to provide additional updates regarding testing milestones, platform enhancements, and future development initiatives as progress continues.
About Medical Care Technologies, Inc.
Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and consumer software innovation. The Company is actively developing technology initiatives involving AI-assisted imaging, computer vision, and scalable software platforms.
Contact Information
Medical Care Technologies, Inc.
Website: https://medicalcaretechnologies.com/
Email: [email protected]
Phone: 1-480-645-0750
Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204
Safe Harbor Statement
This press release contains forward-looking statements that involve risks and uncertainties. These statements include, but are not limited to, expectations regarding product development, testing activities, technology initiatives, future enhancements, and business strategy. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
F.Schneider--AMWN